US indices hit new highs yesterday. Today's lack of trading sessions is causing a slight correction in futures contracts, although it's hard to speak of a clear sell-off. The main US indices remain just over 0.6% down. After the sell-off caused by "Liberation Day," US index quotes rebounded very strongly, recouping losses and reaching new highs. However, the euphoria of the US market has less and less to do with a fundamental improvement in the market situation.
Firstly, the S&P 500 index is being pushed up by a relatively smaller number of companies. Most sectors have performed worse than the broad index since April, with its gains primarily driven by the technology sector. Given the sentiment from 2024, this shouldn't be surprising. However, what might be alarming is that these new index highs are accompanied by over 3 times fewer companies hitting their all-time highs than during the previous index peak.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSecondly, the share of equities in household portfolios remains at a historically record high in 2025, which could pose an increasing challenge to maintaining demand from individual investors.
It's also worth looking at company earnings forecasts. Both estimated sales and EPS for the index for 2025 and 2026 remain over 3% lower than at the February peak. An even greater discrepancy is visible in the Russell 2000 index. It's worth remembering that risks the market has completely abandoned (i.e., higher tariffs and their impact on the US economy) are still on the horizon, which could affect company results.
Comparison of S&P 500 index valuation to projected EPS for 2025 (yellow line) and 2026 (blue line). Source: Bloomberg Finance L.P.
Comparison of Russell 2000 index valuation to projected EPS for 2025 (yellow line) and 2026 (blue line). Source: Bloomberg Finance L.P.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
